Montis VC

Montis VC Research Investment Thesis Montis VC is a Warsaw-based seed-stage venture capital firm backing European founders building breakthrough technologies in energy, industry, and resilience. The official website frames the firm around a structural shift in European industry: energy transition, technological disruption, and the need for more resilient critical systems. Montis looks for companies where deep technological foundations meet tangible industrial applications and where the founding team has ambition to build beyond a local market. External reporting on the March 2026 first close is consistent with this positioning. The Next Web described the new fund as targeting European startups at the intersection of energy transition, industrial technology, and artificial intelligence, including electrification, industrial automation, new energy infrastructure, and AI applied to manufacturing, grids, and logistics. MamStartup similarly described a mandate focused on early-stage technology companies supporting energy and industrial transformation, AI in the economy, climate-aligned productivity, and globally scalable market leaders. Stage Focus Montis VC is primarily a pre-seed and seed investor. The official site says Montis invests at Seed and Pre-Seed, gains early conviction before market consensus forms, and supports companies through multiple rounds. The March 2026 fund announcement said the new vehicle plans 20 to 25 pre-seed and seed investments. Historical Montis Capital activity included later follow-ons and portfolio support, but the current Montis VC product should be treated as an early-stage fund with follow-on capacity, not a growth investor. Check Size The strongest check-size source is Montis's own site, which gives initial tickets of EUR 0.5 million to EUR 2.0 million and capacity to invest up to EUR 5.0 million including follow-ons. TNW repeated that range and noted that approximately half of the new fund is reserved for follow-on rounds into the strongest companies. For matching, the useful first-check range is 500,000 to 2,000,000, while relationship notes should preserve that Montis can continue supporting winners with larger follow-on capital. Lead Tendency Montis should be classified as both lead and participant. Its early-conviction language, operating support, and institutional backing are lead-compatible. At the same time, public Montis Capital predecessor deals show participation in syndicates, including Plenti's EUR 5 million late-seed round led by 4growth VC and joined by Montis Capital, and Proteon Pharmaceuticals' EUR 21 million round with Nutreco, Aqua-Spark, PFR Life Science, Montis Capital, Seventure, and angels. The conservative interpretation is that Montis can lead, co-lead, or participate depending on ownership, syndicate, and company needs. Recent Activity The most important recent event is the March 20, 2026 first close of Montis VC's new EUR 50 million fund. TNW reported backing from the European Investment Fund through REPowerEU, PFR Ventures, family offices, and private investors from Central and Eastern Europe. The same coverage said the predecessor team had deployed roughly EUR 30 million across industry, technology, and climate companies and that the new fund had begun investing, though no Montis VC portfolio names were disclosed at announcement. MamStartup's March 20 coverage reinforced the plan to invest in 20 to 25 technology companies at pre-seed and seed. On May 11, 2026, MamStartup published a podcast/interview with Lukasz Dziekonski that is useful as a current founder-fit signal: the discussion emphasized speed of action, market validation, global ambition for Polish companies, and practical AI use in industrial contexts. Historical activity helps interpret pattern. MyCompanyPolska reported on March 26, 2025 that Montis Capital invested again in Autofixer and noted a prior 2023 seed investment. Nordic9 reported Plenti's February 3, 2023 EUR 5 million late-seed round with Montis Capital participating. Proteon Pharmaceuticals announced an August 10, 2021 EUR 21 million financing round that included Montis Capital. Biotts and PFR sources described Montis Capital investing more than PLN 7 million into Biotts in 2020. These are predecessor-fund events, so they should inform preferences but should not be overstated as deployments from the new 2026 Montis VC vehicle. Portfolio Highlights The official Montis portfolio lists Talkin' Things, Skriware, PlumResearch, Biotts, Proteon Pharmaceuticals, Fresh Inset, Plenti, Port, Autofixer, and buycycle. The portfolio is broad but coherent around physical-world technology, operational complexity, and industrial or resilience relevance. Talkin' Things works on IoT for smart packaging and data collection. Skriware supports STEAM education through robotics and 3D printing. PlumResearch operates in OTT and TV audience measurement. Biotts develops proprietary drug formulas in oncology, dermatology, and autoimmune diseases. Proteon Pharmaceuticals uses bacteriophages as a natural alternative to antibiotics in animal health. Fresh Inset works on post-harvest freshness preservation and food-tech. Plenti provides flexible subscriptions for technology products. Port provides eMobility-as-a-Service for last-mile delivery. Autofixer is a managed marketplace for car parts, and buycycle is a sustainable marketplace for premium pre-owned bikes. Team The official website names Lukasz Dziekonski, Wojtek Szwankowski, and Michal Gaweda as partners. Lukasz has more than 20 years in venture capital, private equity, energy, and infrastructure, with C-suite and board roles and senior management experience at Bank PKO BP. Wojtek has more than 20 years across venture capital, investment banking, and energy, including Goldman Sachs, JP Morgan, and a board role connected to a major Polish energy company sale. Michal has 10 years in finance and venture capital, with experience supporting companies from first institutional rounds through growth, fundraising, and business development. The broader team includes Michal Bas as Director, Jakub Buzalski as Associate, Kamil Misiak as Analyst, Ewa Budziosz as Legal Counsel, and venture partners Tomasz Misiak and Taavi Roivas. Decision Process No public source gives a precise investment committee cadence or decision timeline, so the best structured classification is partnership process and the timeline should remain unknown. The website invites founders building technological breakthroughs in Energy, Industry, or Resilience to contact the firm directly, so a warm introduction should not be treated as required. Founder testimonials on the official site describe Montis as operator-like and hands-on, helping with operations, key hires, fundraising coordination, capex financing, customer introductions, public-institution communication, and hardware production strategy. That points to advisor/co-builder involvement rather than passive capital. Founder Preferences Montis is built for European industrial founders. Strong fits are technical teams building globally scalable technology for energy transition, industrial automation, practical AI, infrastructure, manufacturing, logistics, mobility, hardware, IoT, resilience, life sciences, food/agri-tech, or adjacent deep tech. The May 2026 MamStartup interview highlights speed, market validation, and global mindset. Weak fits are local-only services, superficial AI wrappers, generic consumer apps, teams without technical foundations, or products without industrial, energy, resilience, or European strategic relevance. These exclusions are conservative inferences from the positive thesis, not explicit published exclusions. Geographic Focus Montis is headquartered at Nowogrodzka 10/8 in Warsaw, Poland. The firm describes itself as CEE-native with European reach and says it has a strong presence in Central and Eastern Europe while investing across Europe. External coverage consistently describes the fund as Warsaw-based and Europe-focused, with institutional backing from EIF and PFR and a network spanning Central and Eastern Europe.